SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces plans to report first quarter 2016 financial results prior to the opening of trading on May 4, 2016. Ligand’s CEO John Higgins and CFO Matt Korenberg will discuss the quarterly results later that day during Ligand’s presentation at Deutsche Bank’s 41st Annual Healthcare Conference in Boston. The presentation will be webcast live and also will be archived.
